Sentences with phrase «optigen prcd»
The OptiGen prcd - PRA test allows breeders to present their «Carrier «s and «Affected «s with pride for all their other prize qualities.
http://www.optigen.com/
The OptiGen prcd - PRA mutation test detects only the prcd form of PRA and none other.
But you'll never need to pull any dog because of a «Carrier» or «Affected» OptiGen prcd - PRA reading.
The OptiGen prcd - PRA genetic test was validated for these breeds using DNA samples from the US and from Europe.
The OptiGen prcd test for American Eskimo Dogs provides almost 100 % identification of these dogs.
The OptiGen prcd test for Entlebucher Mountain Dogs provides almost 100 % identification of these dogs.
The OptiGen prcd - PRA test is a DNA - based test that helps you avoid one form of Progressive Retinal Atrophy (PRA).
Not exact matches
ALL OF MY BREEDING DOGS ARE TESTED FOR PRCD - PRA (Progressive Retinal Atrophy) which causes blindness in poodles thru OPTIGEN in Ithaca, New York.
Based on the settlement, Paw Print Genetics now holds the exclusive North American sublicense from OptiGen for PRA - prcd, CEA, CSNB and RD / OSD testing in the U.S. and Canada.
The patents at issue in the case are owned by Cornell University and are licensed to OptiGen for canine genetic testing related to progressive retinal atrophy (PRA - prcd), Collie eye anomaly (CEA), congenital stationary night blindness (CSNB), and Retinal dysplasia / Oculoskeletal dysplasia (RD / OSD).
Optigen today announced that the linkage test for the prcd form of PRA will soon be available in two additional breeds, English Cocker Spaniels, and Chesapeake Bay Retrievers.
OptiGen had previously identified another form of PRA caused by the prcd mutation in this breed.
The Labrador Retriever Club support the use of OFA Data Bases, Penn Hip, CERF and other individual tests such as the test for CNM1, the Optigen tests for the prcd form of PRA in the Labrador Retriever, and the new test for EIC.
June 1, 2005 New Mutation Test for prcd PRA Is Now Available OptiGen, LLC, proudly announces identification of the gene causing canine prcd - PRA (progressive rod - cone degeneration form of Progressive Retinal Atrophy).
OptiGen now offers a direct gene mutation test (mutation test) to detect the prcd - PRA status of any dog among affected breeds.
For any Spanish Water Dog and Australian Shepherds that does not have a diagnosis of PRA, OptiGen will accept samples for prcd - PRA testing at the fee schedule viewable on the website.
The OptiGen test for PRA in the Spanish Water Dog and Australian Shepherds identifies a mutation in the prcd gene that was discovered through extensive research in the laboratories of Dr. Gustavo Aguirre and Dr. Gregory Acland at Cornell University (Zangerl et al., Genomics 88, 551 - 563, 2006).
If a dog with a PRA diagnosis does not have prcd, Optigen will also screen the sample to see if it might have one of the other forms for which they have a test.
Given the multiple forms of PRA, if an Aussie is diagnosed with the disease it would be wise to confirm the diagnosis by having it tested for prcd (which Optigen, the lab offering the test, will do for no charge.)
Multiple Tests for Labrador retrievers or Samoyeds not tested previously by OptiGen: There is a discounted price for ordering multiple tests on one sample (e.g. prcd - PRA and RD / OSD, or XL - PRA and RD / OSD).
To date, OptiGen has tested hundreds of golden retrievers from multiple lines and countries for prcd - PRA and so we can now provide more extensive information on the incidence of the disease in this breed.
OptiGen holds an exclusive international license from Cornell University for the testing of prcd - PRA.
This has been true for the two prcd - PRA affected golden retrievers that we have received at OptiGen that are of diagnostic age.
These conditions are not detectable with OptiGen's test for prcd - PRA.
To order a Toller Progressive Red Cone Degeneration (PRCD) blood test: Detailed instructions are available from OptiGen's website that explain how to ship a sample, request a test and information about the Toller PRCD test.
As announced June 1, 2005, OptiGen now provides a direct mutation test for prcd - PRA.
While the prcd form of PRA (detected by OptiGen's test) is by far the cause of the majority of PRA cases, a small portion remains unidentified.